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ARTICLE
Senescent cells evade immune clearance via
HLA-E-mediated NK and CD8+ T cell inhibition
Branca I. Pereira1,9, Oliver P. Devine1,9, Milica Vukmanovic-Stejic1, Emma S. Chambers 1, Priya Subramanian1,
Neil Patel1, Alex Virasami 2, Neil J. Sebire2, Veronica Kinsler3, Alexis Valdovinos4, Claude Jourdan LeSaux4,
João F. Passos5,6, Antony Antoniou7, Malcom H.A. Rustin1, Judith Campisi4,8 & Arne N. Akbar1
Senescent cells accumulate in human tissues during ageing and contribute to age-related
pathologies. The mechanisms responsible for their accumulation are unclear. Here we show
that senescent dermal ﬁbroblasts express the non-classical MHC molecule HLA-E, which
interacts with the inhibitory receptor NKG2A expressed by NK and highly differentiated CD8
+ T cells to inhibit immune responses against senescent cells. HLA-E expression is induced
by senescence-associated secretary phenotype-related pro-inﬂammatory cytokines, and is
regulated by p38 MAP kinase signalling in vitro. Consistently, HLA-E expression is increased
on senescent cells in human skin sections from old individuals, when compared with those
from young, and in human melanocytic nevi relative to normal skin. Lastly, blocking the
interaction between HLA-E and NKG2A boosts immune responses against senescent cells
in vitro. We thus propose that increased HLA-E expression contributes to persistence of
senescent cells in tissues, thereby suggesting a new strategy for eliminating senescent cells
during ageing.
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Cellular senescence is an evolutionarily conservedmechanism with beneﬁcial effects on tumour suppres-sion1, wound healing2 and tissue regeneration3. During
ageing, however, senescent cells accumulate in tissues and man-
ifest deleterious effects, as they secrete numerous pro-
inﬂammatory mediators as part of a senescence-associated
secretory phenotype (SASP)1,4. The elimination of senescent
cells in mouse models was shown sufﬁcient to delay the onset or
severity of several age-related phenotypes5,6. This has prompted
the development of senolytic drugs that selectively target senes-
cent cells7. Despite successful reversal of age-related pathologies
in animal models, the use of senolytic drugs in humans may be
hampered by their lack of speciﬁcity for senescent cells, leading to
the risk of toxicity7,8. Therefore, alternative approaches that can
be used in isolation or in combination with senolytic drugs to
improve the elimination of senescent cells in humans should be
explored.
Senescent cells can be recognised and eliminated by the
immune system9,10. Different immune cell types including mac-
rophages, neutrophils, natural killer (NK) cells and CD4+ T cells
have been implicated in the surveillance of senescent cells,
depending on the pathophysiological context11–15. Senescent cells
become immunogenic by expressing stimulatory ligands like
MICA/B that bind to NKG2D and activate their killing by NK
cells12,16. Moreover, by secreting chemokines and cytokines,
senescent cells can recruit immune cells into tissues that enable
senescent cell clearance13,17. However, this secretory process may
perpetuate a low-level chronic inﬂammatory state that underlies
many age-related diseases4,18.
Despite the evidence for senescent cell clearance by the
immune system, it is not yet clear why senescent cells accumulate
during ageing and persist at sites of age-related pathologies19. A
decline in immune function may contribute to incomplete elim-
ination of senescent cells with age. Ageing has a great impact in
both innate and adaptive immune systems, a process known as
immunosenescence20,21. Alternatively, changes in major histo-
compatibility complex (MHC) expression can lead to escape from
recognition by the immune system as previously described in
cancer and virally infected cells in vivo22–24. Nevertheless, the
effects of senescence on MHC expression are not fully
understood.
Here, we show that senescent primary human dermal ﬁbro-
blasts express increased levels of the non-classical MHC-class Ib
molecule HLA-E. HLA-E inhibits immune responses against
senescent cells by interacting with the inhibitory receptor NKG2A
expressed on NK and highly differentiated CD8+ T cells.
Accordingly, we ﬁnd an increased frequency of HLA-E expressing
senescent cells in the skin of old compared with young subjects.
HLA-E expression is induced by SASP-related pro-inﬂammatory
cytokines, in particular IL-6 and regulated by p38 signalling
in vitro. Lastly, we show that that blocking HLA-E/NKG2A
interactions in cell culture enhances NK and CD8+ T cell-
mediated cytotoxicity against senescent cells. Taken together,
these ﬁndings suggest that HLA-E expression contributes to the
persistence of senescent cells in tissues. HLA-E may therefore
represent a novel target for the therapeutic elimination of
senescent cells in age-related diseases.
Results
Senescent cells express atypical MHC molecules. Human
ﬁbroblasts were derived from skin explants of healthy volunteers
and exposed to ionising radiation (X-ray) to induce senescence, as
previously described25–27. We conﬁrmed that a low dose of
radiation (10 Gy) effectively arrested cell growth and induced the
expression of senescence-associated markers, such as p16INK4a,
persistent γH2AX foci and senescence-associated-β-galactosidase
(SA-β-Gal) activity (Supplementary Fig. 1). We then examined
the expression of MHC-class I, class II and non-classical MHC
molecules (HLA-E, -F and -G) alongside MHC-related proteins
of the MICA/B and ULBP families. We found that senescent cells
have a signiﬁcantly increased expression of atypical MHC
molecules, such as MICA/B and HLA-E (Fig. 1a). A time course
of cell surface expression of these ligands showed maximal
expression between 7 and 14 days after irradiation (Fig. 1b),
suggesting that MICA/B and HLA-E expression is associated with
the establishment of senescence and is not only a result of acute
DNA damage.
To assess whether this pattern of MHC expression was
common to other forms of senescence, we monitored MHC
expression in cells induced to senesce by oncogenic RAS
activation (H-RASG12V; oncogene-induced senescence; Supple-
mentary Fig. 2A–C) or continuous passaging to replicative
senescence (Supplementary Fig. 2D, E). Independently of the
senescence-inducing stimuli, cells undergoing senescence con-
sistently upregulated HLA-E and MICA/B (Fig. 1c). This
expression was not unique to ﬁbroblasts because human umbilical
vein endothelial cells (HUVECs) exposed to a senescence-
inducing dose of X-ray (Fig. 1c, bottom panels) also increased
expression of HLA-E and MICA/B.
While the expression of MICA/B by senescent cells has been
previously described16,17, the increased expression of HLA-E in
senescent cells has not been shown previously. We used ﬂow
cytometry to conﬁrm that HLA-E was expressed by senescent
cells with additional markers. Non-irradiated ﬁbroblasts
expressed low levels of HLA-E and p16INK4a (Fig. 1d, left panel).
In contrast, the frequency of HLA-E-positive cells was signiﬁ-
cantly higher in irradiated cells frequently co-expressing p16INK4a
and rarely positive for Ki67 (Fig. 1d, right panel), indicating that
the majority of HLA-E expressing cells were in cell-cycle arrest
and expressed markers of senescence.
HLA-E expression by senescent cells is regulated by p38. To
understand the molecular mechanisms regulating the expression
of HLA-E on senescent cells, we investigated two major pathways
that regulate senescence: the DNA-damage response (DDR) and
p38 signalling. The DDR was previously implicated in increasing
MICA/B expression in human and mouse ﬁbroblasts exposed to
genotoxic stress28,29. We therefore asked whether the DDR was
also involved in regulating HLA-E expression after irradiation.
We pretreated ﬁbroblasts with the ATM inhibitor KU-55933
(10 μM) or DMSO 12 h before irradiation, and continuously
thereafter over a period of 7 days. We monitored MHC expres-
sion by ﬂow cytometry in non-irradiated cells and in vehicle- or
KU-55933-treated cells 1, 4 and 7 days after irradiation. Con-
sistent with previous reports, inhibition of ATM signiﬁcantly
decreased MICA/B expression after irradiation (Supplementary
Fig. 3A). By contrast, ATM inhibition did not decrease the
expression of HLA-E on irradiated ﬁbroblasts (Supplementary
Fig. 3B). Although we cannot exclude that HLA-E expression on
senescent cells may be affected by the DNA-damage response, the
increased expression of HLA-E at day 7 and day 14 after irra-
diation, when the expression of γH2AX is decreasing (Fig. 2a),
suggests that the DNA-damage response is not necessary for
HLA-E expression. By contrast, the similar kinetics of HLA-E and
p38 phosphorylation at Thr180/Tyr182 (Fig. 2a) suggested a role
of p38 signalling in regulating HLA-E expression on senescent
cells. To test this, we pretreated senescent cells with the p38
inhibitor BIRB79630,31 or DMSO before irradiation and con-
tinuously thereafter for 7 days. As indicated by the levels of
phosphorylated heat-shock protein 27 (p-Hsp27), a downstream
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target of p38, BIRB796 inhibited the activation of p38 after
irradiation (Fig. 2b). Strikingly, the inhibitor also prevented the
upregulation of HLA-E after irradiation, suggesting that activa-
tion of p38 is required for the upregulation of HLA-E expression
after irradiation. These ﬁndings were conﬁrmed in the oncogene-
induced model of senescence (Fig. 2c) and also with an alternative
p38 inhibitor SB203580, which inhibits p38 by a mechanism that
differs from that used by BIRB79630 (Fig. 2d). Interestingly, we
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Fig. 1 Senescent human ﬁbroblasts express atypical MHC molecules. a Primary human ﬁbroblasts were derived from the human skin and induced to
senesce by ionising radiation (IR, 10 Gy X-ray). MHC expression by senescent ﬁbroblasts (white bars) analysed at day 14 after IR using ﬂow cytometry
(n= 6 different donors for MHC-I, HLA-E and MICA/B, n= 4 for MHC-II, HLA-G and ULBP). Mean ﬂuorescence intensity (MFI) values are shown as fold
change compared with non-irradiated controls, set as one (black bars). b Time course of HLA-E and MICA/B expression at the indicated intervals after
irradiation (n= 5). c Representative FACS plots of the total MHC-I, HLA-E and MICA/B expression in senescent ﬁbroblasts induced by ionising radiation
(DNA-damage induced senescence), H-RAS activation (oncogene-induced senescence) or continuous passaging (replicative senescence). MHC
expression was compared between senescent (black lines), non-senescent (ﬁlled histograms) and isotype controls (dashed lines). Human umbilical vein
endothelial cells (HUVECs) were irradiated (10 Gy), and MHC expression analysed by ﬂow cytometry as previously described. d Flow-cytometry analysis
of co-expression of HLA-E and Ki67 and p16INK4a on irradiated ﬁbroblasts (day 14 after irradiation) and non-irradiated controls. Numbers indicate
percentages of cells per quadrant. The data are representative of at least three independent experiments from distinct samples. Statistical signiﬁcance
calculated with Mann–Whitney U test (a) and repeated measures ANOVA with Bonferroni correction (b). The data presented as means ± standard error of
the mean (SEM). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
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found no signiﬁcant effect of p38 inhibition on MICA/B
expression (Fig. 2e), suggesting that different pathways regulate
the expression of MICA/B and HLA-E in senescent cells.
HLA-E expression is induced by SASP cytokines. Since p38 is a
key regulator of the SASP32, we asked whether SASP factors could
increase HLA-E expression in a paracrine manner. We exposed
early-passage ﬁbroblasts to conditioned media (CM) from
senescent or non-senescent cells. Non-senescent cells increased
HLA-E expression within 48 h of exposure to CM from senescent
cells (Fig. 2f).
We used cytometric-bead arrays to measure SASP factors
secreted by senescent cells. We identiﬁed IL-6, IL-8 and MCP-1 as
the most highly secreted SASP-related factors, as previously
reported32 (Fig. 2g). Exposing non-senescent ﬁbroblasts to these
factors revealed a signiﬁcant effect of IL-6, alone or in
combination with other factors, in stimulating HLA-E expression
(Fig. 2h). We cannot exclude, however, that other factors other
than SASP-related pro-inﬂammatory cytokines may contribute to
the upregulation of HLA-E in senescent cells.
HLA-E ligates NKG2A and NKG2C on NK cells and CD8+
T cells. HLA-E and MICA/B bind receptors belonging to the
Natural Killer Group 2 (NKG2) family, which regulate NK cell
function33. MICA/B, and ULBP antigens, bind the stimulatory
NK cell receptor NKG2D29, whereas HLA-E binds both the
inhibitory NKG2A and stimulatory NKG2C receptors34. We
analysed the distribution of NKG2 receptors on peripheral blood
mononuclear cells (PBMCs) from healthy human volunteers (n
= 27; mean age 49.9; range, 27–83 years) and found that NKG2D
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Fig. 2 HLA-E expression on senescent cells is regulated by p38 and induced by IL-6. a Representative immunoblot of human ﬁbroblasts at the indicated
intervals after IR showing the kinetics of HLA-E, p38 (Thr180/Tyr182) and γH2AX (Ser139) phosphorylation. b Human ﬁbroblasts were treated with
p38 inhibitor BIRB796 (0.5 μM) or DMSO 12 h before, and for 7 days after IR. Immunoblot of HLA-E expression at the indicated intervals after IR compared
with DMSO-treated controls. Undetectable levels of phospho-Hsp27 (p-Hsp27) conﬁrm effective inhibition of p38. c IMR-90 ER:STOP/ER:RAS cells
treated with 4-OHT to induce senescence (as demonstrated in Supplementary Fig. 2A–C) and treated with BIRB796 (0.5 μM) or DMSO over 7 days,
followed by protein extraction and immunoblot analysis of HLA-E and p-Hsp27. GAPDH served as a loading control in a–c. Uncropped immunoblots are
provided in the Source Data ﬁle. d The summary data of HLA-E and (e) MICA/B expression analysed by ﬂow cytometry on irradiated ﬁbroblasts treated
with SB203580 (10 μM), compared with DMSO-treated and non-irradiated controls (n= 5). f Flow-cytometry analysis of HLA-E expression on ﬁbroblasts
exposed to the conditioned medium (CM) from senescent (SEN) or non-senescent (NS) cells for 48 h (n= 5). g Supernatant from irradiated senescent or
early-passage ﬁbroblasts analysed by cytokine-bead arrays to measure secreted cytokines (in pg/mL) (n= 12). h Fibroblasts were exposed to IL-6
(20 ng/mL), IL-8 (20 ng/mL), IL-1β (20 ng/mL) or IFNα (500 U/mL) or combinations of these for 48 h and analysed for HLA-E expression by ﬂow
cytometry (n= 6). The data are representative of at least three independent experiments from distinct samples. Comparison between groups performed
with Kruskal–Wallis test in (d), (e) and Mann–Whitney U test in (f), (g) and (h). The data presented as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001
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was highly expressed on NK (included in the CD3− subset) and
CD8+ T cells (Fig. 3a), as previously shown29. Expression of
NKG2A and NKG2C, the cognate receptors for HLA-E, was not
restricted to NK cells, and a proportion of CD8+ T cells also
expressed these receptors (Fig. 3b, c). Human CD8+ T cells can
be stratiﬁed by their relative expression of the co-stimulatory
receptors CD28 and CD27, deﬁning early (CD28+CD27+),
intermediate (CD28−CD27+) and late (CD28−CD27−) stages of
differentiation (Fig. 3d). The majority of NKG2A+ and NKG2C+
CD8+ T cells were highly differentiated (CD28−CD27−) cells
(Fig. 3e, f), a subset that is expanded with age35. We found the
proportion of NKG2A+ within the highly differentiated subset of
CD8+ T cells to be signiﬁcantly positively correlated with age
(Supplementary Fig. 5A). This effect was not seen in the NKG2C
+ compartment (Supplementary Fig. 5B). No association was
found between the frequency of NKG2A+ cells and age within the
CD3− compartment (Supplementary Fig. 5C). Although we did
not investigate the expression of NKG2A directly on NK cells in
the CD3− compartment, previous studies show that the expres-
sion of this receptor does not change on NK cells during ageing36,
while others report an age-associated decrease in expression37.
NK and CD8+ T cells target senescent ﬁbroblasts via NKG2D.
NK cells have been implicated in the surveillance and elimination
of senescent cells through interaction between NKG2D and its
ligands expressed on senescent cells12,15–17. Since CD8+ T lym-
phocytes also express the cognate receptors for MICA/B and
HLA-E, we asked whether these cells could also participate in
immune surveillance of senescent cells in analogy with NK cells.
To avoid allogeneic reactions with T cells, we developed a co-
culture system with skin-derived primary human ﬁbroblasts and
immune cells obtained from the same individuals (Fig. 4a). After
inducing senescence with ionising radiation, we co-cultured
senescent and non-senescent ﬁbroblasts with freshly isolated
autologous NK and CD8+ T cells.
Consistent with previous reports11,12, NK cells preferentially
targeted senescent cells, as shown by signiﬁcantly higher levels of
active caspase 3 (measuring cell apoptosis) in senescent versus
non-senescent ﬁbroblasts when cultured with NK cells (Fig. 4b).
Notably, CD8+ T cells could also induce signiﬁcant activation of
caspase 3 in senescent cells compared with non-senescent
controls (Fig. 4b). These results were conﬁrmed using a
CD107a-based degranulation assay as a surrogate marker of
c
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Fig. 3 MICA/B and HLA-E bind NKG2 receptors expressed on NK and CD8+ T cells. Distribution of (a) NKG2D+, (b) NKG2A+ and (c) NKG2C+ cells on
the indicated subsets of human lymphocytes from blood of healthy volunteers (n= 27; mean age 49.9; range, 27–83), analysed by ﬂow cytometry. FACS
sequential gating strategies represented in Supplementary Fig. 4. d Human CD8+ T cells were stratiﬁed according to CD27 and CD28 expression in early-
(CD27+28+), intermediate- (CD27+28−) and late-differentiated (CD27−28) cells, as represented in the ﬂow-cytometry plot. e, f The summary data of
the distribution of NKG2A+ (e) and NKG2C+ (f) cells within early-, intermediate- and late-differentiated CD8+ T cells gated as in (d) in the same donors
(n= 27; mean age 49.9; range, 27–83). Comparison between groups done with Friedman test with Dunn's correction for multiple comparisons in (e) and
(f). The data presented as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
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cytotoxicity38, indicating that both NK and CD8+ T cells can
target senescent ﬁbroblasts in vitro (Fig. 4c). Pre-incubation of
effector cells with NKG2D blocking antibody (1D11) decreased
both NK and CD8+ T-cell degranulation towards senescent
ﬁbroblasts as compared with cells pretreated with a matched
isotype control (Fig. 4c). By contrast, pre-incubation with
NKG2A blocking antibody (Z199) signiﬁcantly boosted the
response of NK cells (Fig. 4c) and CD8+ T cells (Fig. 4c) against
senescent cells, as compared with matched isotype controls.
Collectively, these ﬁndings indicate that both NK and CD8+
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T cells can kill senescent cells by an NKG2D-dependent
mechanism, and that positive signals delivered by NKG2D
ligation by MICA/B may be blocked if the inhibitory receptor
NKG2A is engaged with its ligand HLA-E.
NKG2A/HLA-E blockade enhances senescent cell surveillance.
To directly investigate the role of HLA-E in inhibiting immune
responses against senescent cells, we used RNA interference to
inhibit HLA-E expression. At 36 h post transfection, the expres-
sion of HLA-E on senescent ﬁbroblasts was decreased upon
transfection with siRNA against HLA-E compared with the
siRNA control (Supplementary Fig. 5D). This resulted in a sig-
niﬁcant increase in degranulation by autologous NK and CD8+
T cells (Fig. 4d), as compared with cells transfected with a
scrambled siRNA control. These ﬁndings suggest that HLA-E
expression on senescent cells decreases their susceptibility to
elimination by NK and CD8+ T cells that express the inhibitory
receptor NKG2A. The differences noted in the CD107a degra-
nulation assay between antibody blocking experiments and
experiments using siRNA transfection are most likely associated
with the transfection protocol and incomplete silencing of HLA-E
expression after transfection (Supplementary Fig. 5D).
Relevance of HLA-E expression on senescent cells in vivo. To
determine whether HLA-E expression was also elevated on
murine senescent cells in vivo, we used p16-3MR reporter mice
model that allows the identiﬁcation of p16INK4a-positive (senes-
cent) cells via the p16INK4a promoter driven expression of luci-
ferase (Fig. 5a). Importantly, it also enables the selective
elimination of senescent cells by administration of ganciclovir
(GCV) through p16INK4a promoter driven expression of the
herpes simplex virus 1 (HSV-1) thymidine kinase (HSV-TK)2.
We treated p16-3MR mice with the genotoxic drug bleomycin to
induce senescence and ﬁbrosis in the lung39, with or without
ganciclovir to eliminate senescent cells (Fig. 5b). We harvested
whole lungs and analysed them by quantitative polymerase chain
reaction for genes encoding Qa-1b (H2-T23, the mouse homo-
logue of HLA-E), p16INK4a (CDKN2A) and collagen (COL1A1) as
a proxy marker of ﬁbrosis. CDKN2A mRNA levels increased
14 days after treatment with bleomycin (Fig. 5c), as did H2-T23
mRNA levels (Fig. 5d). Furthermore, when mice were treated
with GCV to eliminate p16Ink4a-positive cells, H2-T23 gene
expression declined to control levels (Fig. 5d). Likewise, COL1A1
mRNA levels increased upon induction of senescence by bleo-
mycin and declined after eliminating senescent cells with GCV.
These results suggest that ﬁbrosis is associated with the devel-
opment of senescence and is alleviated when senescent cells are
cleared (Fig. 5e).
To assess the biological relevance of HLA-E expression by
senescent cells in humans, we studied congenital melanocytic
nevi (Fig. 6). Previous studies showed that melanocytic nevi are
enriched with cells expressing markers of senescence and thus
are likely an example of oncogene-induced senescence
in vivo40,41. We immunostained formalin-ﬁxed, parafﬁn-
embedded (FFPE) tissue arrays of congenital and acquired
human melanocytic nevi for HLA-E expression (Fig. 6a). We
analysed the staining using Image Analysis Software and scored
HLA-E expression based on the percentage of HLA-E+ cells,
ranking as negative (score 0: between 0 and 1%), mild (score 1:
1–5%), moderate (score 2: 5–10%) or intense (score 3: >10%).
In each array, normal skin and melanoma samples were used as
controls (Supplementary Fig. 6). Among 24 lesions studied,
HLA-E expression was detectable in most (23/24) human
melanocytic nevi. In 10/24 (41.7%) lesions, we observed strong
positivity for HLA-E (score 3), with frequencies of HLA-E
positive cells up to 30% (Supplementary Table 1). Sections were
also stained for Ki67 as a marker of proliferation, which
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demonstrated that cells expressing HLA-E were rarely Ki67
positive (Fig. 6b). To determine levels of immune cell
inﬁltration, the same tissue arrays were stained for CD8
(Fig. 6c) and the percentage of these cells was calculated using
the same software (mean 5.29 ± 4.01%, range 0.05–16.5%). Co-
staining for CD8 and HLA-E showed that CD8+ cells
frequently co-localised with HLA-E+ cells (Fig. 6d). As NK
cells can also stain positively for CD8, tissue arrays were co-
stained with CD3 to distinguish NK from T cells. This analysis
conﬁrmed the presence of CD3+ CD8+ T lymphocytes,
however, these cells did not account for all the immune cell
inﬁltration (Fig. 6e). We conclude that both T cells and NK cells
associate with HLA-E expressing cells in melanocytic nevi, and
we observed a signiﬁcant positive correlation between the
frequency of HLA-E+ cells in melanocytic nevi and the
percentage of CD8+ T-cell inﬁltration in melanocytic nevi
(Fig. 6f). Therefore, HLA-E expression is common in human
melanocytic nevi and may explain why these nevi persist for
decades in tissues, despite the presence of immune cell
inﬁltrates.
HLA-E expression by senescent ﬁbroblasts in human skin.
Senescent cells have been shown to increase in many tissues
during ageing, including in the skin42. To investigate whether
senescent cells express HLA-E in healthy individuals in vivo, we
analysed histological sections of normal human skin from young
(<40 years) and old (>65 years) healthy donors using confocal
microscopy. Firstly, we identiﬁed non-senescent (Fig. 7a, top
panels) and senescent cells (Fig. 7a, bottom panels) by staining for
telomere-associated DNA-damage foci (TAF; left hand panels) or
p16INK4A (Fig. 7a, right panels). In sections that were stained for
both TAF and p16INK4A, there was a signiﬁcant correlation
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between both senescent markers (Fig. 7b). We subsequently used
TAF staining alone to identify senescent cells. There was a highly
signiﬁcant correlation between senescent (TAF+) cells in the
interstitial dermis and increasing donor age (Fig. 7c).
As seen in representative confocal micrographs of interstitial
dermal cells of the human skin (Fig. 7d), TAF+ cells co-stain for
HLA-E conﬁrming that HLA-E expressing cells display markers
of senescence. There was a positive correlation between the
frequencies of HLA-E+ and TAF+ cells (Fig. 7e) and HLA-E+
and p16INK4A+ cells in the same skin sections (Fig. 7f). Finally,
we found a signiﬁcant increase in the frequency of HLA-E+ cells
in older donors as compared with young (Fig. 7g). A signiﬁcantly
higher proportion of senescent (TAF+) cells expressed HLA-E+
compared with non-senescent (TAF−) cells (Fig. 7h). The
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majority of TAF+ senescent cells were dermal ﬁbroblasts, a subset
of which we identiﬁed as staining positive for the ﬁbroblast-
speciﬁc protein-1 (FSP1)43 (Supplementary Fig. 7A). A similar
proportion of FSP1+ cells were found in the interstitial dermis of
young and old subjects (Supplementary Fig. 7B). There was a
signiﬁcantly increased frequency of TAF+ senescent cells in both
FSP1+ and FSP1− populations in the skin of old donors
compared with young (Supplementary Fig. 7C, D), indicating
that other cells as well as ﬁbroblasts contribute to the senescent
cell population in older individuals.
Discussion
This study identiﬁes a mechanism of immune evasion that may
contribute to the persistence of senescent cells in tissues. We
found that ﬁbroblast senescence is associated with an upregula-
tion of HLA-E, which has restricted expression in non-senescent
cells. The increased HLA-E expression on senescent ﬁbroblasts
impairs their elimination by NK and CD8+ T-cells expressing the
inhibitory receptor NKG2A. Previous transcriptomic studies of
replicative senescent human ﬁbroblasts included HLA-E in the
list of genes that increased more than twofold compared with
proliferative cells, corroborating our ﬁndings44. Functionally, we
show that both NK and CD8+ T lymphocytes can target senes-
cent cells through an NKG2D-dependent mechanism. Despite
expressing high levels of NKG2D, the simultaneous presence of
the inhibitory receptor NKG2A in NK and CD8+ T cells may
compromise the immune-mediated clearance of senescent cells.
Even if the activating receptor NKG2C is co-expressed on the
same effector cell, the afﬁnity of HLA-E binding to NKG2C is
lower compared with NKG2A and inhibitory signals dominate
and override activation signals45. The expansion of NKG2A+
CD8+ T cells with age may explain why the immune system is
less effective at eliminating senescent cells in old subjects. Like-
wise, the composition and function of NK cells is highly sus-
ceptible to ageing20,36; however, we did not ﬁnd signiﬁcant age-
related differences in the frequency of NKG2A+ cells within the
CD3− compartment in line with previous studies36,46, whereas
other studies suggest that the frequency of NKG2A+ NK cells
may decrease with age37. Despite this, the relatively high
expression of NKG2A receptors on NK cells (Fig. 3b) is likely to
have important implications in the surveillance of senescent cells.
This is supported by the more pronounced effect of NKG2A
inhibition in NK compared with CD8+ T cells (Fig. 4c). Because
the responses to NKG2D and NKG2A blockade were only partial,
we cannot exclude that additional receptors on NK and CD8+
T cells may be important in this interplay, as suggested
previously15.
NK cells and their crosstalk with other immune cells have been
shown to be major mediators in the clearance of senescent cells in
the context of liver ﬁbrosis12,16, hepatocellular carcinoma17 or
multiple myeloma15. This suggests that the mechanism of
senescent cell persistence through HLA-E expression leading to
inhibition of T and NK-cell killing may also be relevant in these
contexts. However, it may not be applicable to other pathophy-
siological contexts, where the elimination of senescent cells seems
to be dependent on other immune cells in particular monocytes/
macrophages13,14. One situation where decreased senescent cell
clearance may be important is in the persistence of melanocytic
nevi that contain senescent cells that co-localise with immune
cells. The expression of HLA-E at these sites would explain why
these cells are not cleared.
Mechanistically, we demonstrate that HLA-E expression on
senescent cells is regulated by p38 signalling in vitro. Previous
studies showed that pro-inﬂammatory cytokines such as IL-1β,
TNF and IFN-γ can induce HLA-E expression on endothelial
cells47. We found that the SASP-related cytokine IL-6 induced
HLA-E expression on non-senescent cells in a paracrine fashion.
IL-6 has been implicated in many of the SASP-induced effects on
surrounding cells, including epithelial-to-mesenchymal transi-
tions, tumour progression and ﬁbrinogenesis48. Moreover,
increased levels of IL-6 and IL-8 are found in the sera of elderly
patients, and contribute to the systemic low-level chronic
inﬂammation that has been linked to many age-related diseases18.
The upregulation of HLA-E expression by IL-6 thus suggests that
sustained inﬂammation may also contribute to the persistence of
senescent cells in tissues, further contributing to the pathogenesis
of age-related diseases.
We cannot exclude that other mechanisms may contribute to
the overexpression of HLA-E on senescent cells. It would be
interesting to investigate whether factors other than SASP-related
pro-inﬂammatory cytokines such as reactive oxygen species may
contribute to the upregulation of HLA-E in senescent cells. While
HLA-E mRNA can be found in almost all nucleated cells, the
stability of HLA-E expression at the cell surface depends on the
availability of highly conserved nonameric peptides commonly
generated after trimming of the leader sequence of classical
MHC-class I molecules49. There is accumulating evidence that
HLA-E can present a diverse repertoire of peptides, derived from
viral particles, heat-shock proteins50 and other stress-induced
peptides51. Recent studies indicate that CD8+ T cells can also
recognise foreign peptides presented by HLA-E via the TCR eli-
citing CD8+ T cell-speciﬁc immune responses52. Further inves-
tigation is required to determine whether HLA-E can present
senescent-speciﬁc antigens in this context.
Collectively, our ﬁndings support a model for immune-
mediated senescent cell persistence where a balance between
activating and inhibitory signals will determine the outcome of
the NK and T-cell immune response to senescent cells. From a
therapeutic perspective, interventions blocking the interaction
between HLA-E and the inhibitory receptor NKG2A may
represent promising strategies to improve the immune clearance
of senescent cells. Humanised monoclonal antibodies targeting
NKG2A (Monalizumab) are readily available and currently in
clinical trials for cancer53. It will be important to determine how
Fig. 7 HLA-E expression by senescent ﬁbroblasts in human skin during ageing. a Histological sections from healthy donors were stained for DAPI (blue),
TelC (red punctate intranuclear), γH2AX S139 (green) and p16INK4A (white). Telomere-associated γH2AX foci (TAF) are shown (white arrow heads)
in non-senescent (NSEN; top panels) and senescent (SEN; bottom panels) cells in the dermis of the human skin. Original image shown in Supplementary
Fig. 7E and provided in the Source Data ﬁle. Scatterplot showing the relationship between the frequency of p16INK4A+ cells (b) and donor age (c) with the
frequency of TAF+ cells in the interstitial dermis of the human skin. d Skin sections were stained for DAPI (blue), TelC (red punctate intranuclear), γH2AX
S139 (green) and HLA-E (white). Telomere-associated γH2AX foci (TAF) are shown (white arrow heads) in senescent HLA-E+ cells (yellow asterisks) of
the human dermis. The signal intensity of TelC and γH2AX along lines (a) and (b) are represented in histogram format and both signals overlap in the
senescent, but not the non-senescent cell. e Correlation of HLA-E+ cells and TAF+ cells in the interstitial dermis of human skin. f Correlation of HLA-E+
cells and p16INK4A+ cells in the interstitial dermis of the human skin. g The frequency of HLA-E+ cells present in the superﬁcial dermis of young (n= 4) and
old (n= 5) human skin. h The frequency of HLA-E+ cells in the TAF+ and TAF− populations in the dermis of young (n= 4) and old (n= 5) human skin.
The data are represented as mean ± SEM. Statistical signiﬁcance calculated with Mann–Whitney U test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
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the combination of immune modulators such as anti-NKG2A,
senolytic drugs as well as direct inhibitors of the SASP can be
used for the elimination of senescent cells in vivo54,55.
Methods
Blood and skin sample collection. Blood and skin samples were obtained from
healthy research volunteers. The study was approved by the Research Ethics
Committee of University College London (06/Q0502/92) and the National Health
Service Research Ethics Service (11/LO/1846). All volunteers provided written,
informed consent. In total, 5 -mm skin punch biopsies were obtained from sun-
protected areas of the forearm of healthy young subjects (<40 years of age) and old
subjects (>65 years of age). Biopsies were either snap-frozen in liquid nitrogen for
later histological analysis or prepared for skin-explant culture to derive primary
ﬁbroblasts as described25. Peripheral blood mononuclear cells (PBMC) were iso-
lated by density-gradient centrifugation (Ficoll–Hypaque, Amersham) from blood
of healthy donors. Untouched NK and CD8+ T cells were freshly isolated by
magnetic activated cell sorting (MACS, Miltenyi Biotec) using a negative selection
procedure (>95% purity).
Induction of senescence. Primary human ﬁbroblasts were induced to senesce by
exposure to X-ray radiation at a total dose of 10 Gy at a rate of 5 Gy/min.
Oncogene-induced senescence was induced in IMR-90 human diploid ﬁbroblasts
transduced with a vector expressing H-RASG12V (ER:RAS) or a control insert
(STOP), both containing a tamoxifen-inducible oestrogen receptor fusion protein
(ER:STOP). Cells were treated with 4-hydroxytamoxifen (4-OHT) (Sigma-Aldrich)
at 200 nM to activate H-RASG12V, as described56. Replicative senescence was
induced by continuous passaging of ﬁbroblasts until they reached a plateau in their
growth curve. Cumulative population doublings (PD) were calculated using the
following equation:
PD ¼ log nc  log ns
log 2
ð1Þ
where nc represents the number of cells counted after expansion and ns represents
the number of cells seeded.
Senescence-associated β-galactosidase staining. Cells were ﬁxed and stained
using the Senescence-Associated β-Galactosidase Staining Kit (Cell Signaling,
9860), following the manufacturer's instructions. After staining, cells were incu-
bated for 12–16 h at 37 °C, then visualised by phase-contrast microscopy.
Telomere ﬂuorescence in situ hybridisation. Six micrometers cryosections were
obtained from skin biopsies and prepared on poly-L-lysine coated glass slides
(Cytospin, Thermo Scientiﬁc). Staining for telomere-associated ɣH2AX foci (TAF)
was then performed. Sections were stained for ɣH2AX (Ser139, Cell Signaling
#9718, 1:250), p16INK4a (Abcam, ab108349, 1:100 or Sigma SAB5300499, 1:100)
and HLA-E (clone 3D12, eBioscience, 1:100), followed by incubation with sec-
ondary antibody conjugated to various ﬂuorochromes and washed in formamide/
SSC prior to mounting with Vectorshield/DAPI (Vector Laboratories). Slides were
air dried prior to hybridisation for 2 h with 40 pM PNA probe targeting the TelC
telomeric repeat (Panagene, TelC Cy3, #14 1224PL-01). Imaging of TAF foci was
then performed using a Leica SPE2 confocal microscope (Leica Microsystem).
Imaging consisted of obtaining Z-stacks with a step-size of 0.5 μm. Analysis was
performed using Fiji image analysis software (Fiji.sc).
Western blotting. Cells were harvested by trypsinization, washed in PBS and lysed
with radio-immunoprecipitation assay (RIPA) buffer (Sigma-Aldrich) supple-
mented with protease and phosphatase inhibitors (GE Healthcare) for 30 min on
ice. Protein concentrations were determined using the Pierce BCA Protein Assay
Kit (Thermo Scientiﬁc). Cell lysates (10 or 20 μg of the total protein) were diluted
in SDS sample buffer with reducing agent (NuPage, Life Tecnologies) and boiled
for 5 min at 95 °C. Cell lysates were separated by protein electrophoresis at 120 V
for 2 h using 10% Bis-Tris pre-cast gels (NuPage) and transferred overnight at 4 °C
onto Hybond-P PVDF membranes (GE Healthcare). After blocking, membranes
were probed with primary antibodies overnight at 4 °C, washed and incubated with
HRP-conjugated secondary antibodies (GE Healthcare, 1:4000) for 1 h at room
temperature. Antibodies were detected using the ECL detection kit (GE Health-
care). Prior to re-probing with different antibodies, membranes were stripped at 37
°C in agitation using Restore stripping buffer (Thermo Scientiﬁc). Protein bands
were quantiﬁed using ImageJ software. The integrated density of each band was
measured using the gel analysis function of ImageJ, normalised to GAPDH. Pri-
mary antibodies were rabbit polyclonal anti-histone γH2A.X (pS139), anti-Hsp27
(pS78), anti-p38 MAPK (pThr180/Tyr182), anti-p53 and anti–GAPDH (all from
Cell Signaling). For HLA-E expression, we used mouse monoclonal anti-HLA-E
(MEM-E/02, Santa Cruz Biotechnology), as described57. All primary antibodies
were used at a dilution of 1:1000. Uncropped immunoblots are provided in the
Source Data ﬁle.
Flow cytometry. For ﬁbroblast staining, cells were washed in PBS and harvested
after trypsin treatment, centrifuged at 1200 rpm for 10 min and resuspended in
ice-cold PBS. Flow-cytometric analysis of surface expression of MHC molecules
was performed after a 30-min incubation at 4 °C in the presence of saturating
concentrations of antibodies (Supplementary Table 2) and a live/dead stain.
Proliferation was assessed by staining for Ki67 (mouse anti-human Ki-67 set,
BD Biosciences), p16Ink4a expression was performed using PE Mouse anti-
Human p16 set (BD Biosciences, 556561). For the detection of γH2AX (Ser139),
we used phosphoﬂow cytometry after ﬁxation (10 min at 37 °C with Cytoﬁx
Buffer), permeabilisation (30 min at 4 °C with ice-cold Perm Buffer III),
washing (twice with Stain Buffer, all from BD Biosciences) and incubation
for 30 min at room temperature with Alexa Fluor 488-conjugated antibody
to γH2AX (Ser139) (clone 2F3; BioLegend). Multi-parametric ﬂow cytometry
was used for phenotypic analysis of surface expression of NK-cell receptors
(antibodies listed in Supplementary Table 2). Samples were acquired on a
LSR II ﬂow cytometer (BD Biosciences) and analysed using FlowJo software
(TreeStar).
Autologous co-culture system. Paired blood and skin samples were obtained
from healthy donors (n= 5, age range 20–46). Skin-derived primary human
ﬁbroblasts were irradiated and allowed to recover in culture until they developed a
senescent phenotype. Senescent ﬁbroblasts (14–21 days after irradiation) were
seeded onto ﬂat-bottom 48-well plates (20 × 104 cells per well) and grown to
conﬂuence at 37 °C and 5% CO2. Early-passage ﬁbroblasts (passages 3–9) were
used as non-senescent controls. When conﬂuent, monolayers were washed and
incubated with IL-2 activated NK and CD8+ T cells freshly isolated from the same
individuals.
Cytotoxicity assays. Cytotoxicity was assessed after 6-h incubation by quantifying
active caspase 3 levels in target cells using ﬂow cytometry (Caspase 3 Assay kit,
556485, BD Biosciences). Baseline expression of caspase 3 in ﬁbroblasts incubated
with medium only was used as a negative control. Fibroblasts treated with
camptothecin (8 μg/mL; Sigma-Aldrich) were used as positive controls. Alter-
natively, CD107a (lysosomal-associated membrane protein-1, LAMP-1) expression
was used as a marker of CD8+ T and NK cells degranulation, as described38. The
data are presented as an index calculated as (sample degranulation–spontaneous
degranulation)/(maximum degranulation−spontaneous degranulation) × 100.
Antibody blockade experiments. Freshly puriﬁed NK and CD8+ T cells were pre-
incubated with 1 μg/mL anti-NKG2D (1D11, eBioscience), 1 μg/mL anti-NKG2A
(Z199, Beckman Coulter) or respective isotype controls followed by incubation
with senescent or non-senescent ﬁbroblasts.
Transfection of cells with small interfering RNAs. Primary human ﬁbroblasts
were transfected with siRNAs for HLA-E (sc-62470, Santa Cruz Biotechnology) or
a control siRNA (sc-37007, Santa Cruz Biotechnology) using the Amaxa Human
Dermal Fibroblast Nucleofector Kit (Lonza) as per the manufacturer's protocol.
HLA-E siRNA (h) is a pool of three siRNAs that inhibit HLA-E expression.
Transfection efﬁciency was conﬁrmed by measuring protein content by ﬂow
cytometry, typically 36–48 h after transfection.
Treatment with inhibitors in vitro. Cells were treated with 10 μM KU-55933
(EMD Millipore) or 10 μM CGK733 (Calbiochem). Cells were treated with 0.5 μM
BIRB796 (Selleck Chemicals) or 10 μM SB203580 (Calbiochem) for 12 h before and
continuously after irradiation over 7 days, with daily replenishment with fresh
media and inhibitors. A solution of 0.1% DMSO in the DMEM was used as a
vehicle control.
Cytometric bead array. Conditioned media from senescent and early-passage
ﬁbroblasts were collected and assessed for cytokine production according to
the manufacturer's protocol. Samples were analysed in a BD Verse ﬂow
cytometer (BD Biosciences). The lower limit of detection for each analyte was
1.5 pg/mL.
Treatment with conditioned medium and cytokines. Conditioned media (CM)
were generated by culturing cells in the serum-free DMEM supplemented with
penicillin/streptomycin for 24 h. CM were normalised to the cell number and
clariﬁed by centrifugation and ﬁltration and diluted 1:1 with 10% FBS–DMEM.
Early-passage ﬁbroblasts were incubated with diluted CM for 48 h before analysis
for HLA-E expression by ﬂow cytometry. Recombinant human cytokines IL-6 (20
ng/mL), IL-8 (20 ng/mL), IL-1β (20 ng/mL) or IFNα (500 U/mL, all from Pepro-
tech UK) were diluted in complete DMEM.
Tissue arrays of congenital melanocytic nevi. Tissue arrays of congenital mel-
anocytic nevi (CMN) were obtained from the Paediatric Dermatology Department
at the Great Ormond Street Hospital. Samples in these tissue arrays were taken as
part of clinical care, and informed consent was obtained from all patients, after
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approval by the Research Ethics Committee of Great Ormond Street Hospital and
the University College London Institute of Child Health. Each array included
14–16 formalin-ﬁxed parafﬁn-embedded sections of CMN from different patients
and normal skin, acquired melanocytic nevus and malignant melanoma as
controls.
Immunohistochemical staining. Immunohistochemical staining of tissue arrays of
congenital melanocytic nevi was performed on the automated Leica BOND-MAX
immunostainer (Leica Biosystems) following deparafﬁnization and heat-induced
epitope retrieval (with Leica HIER solution ER2 at pH9). Staining was detected
using Leica Bond polymers. Dual staining of HLA-E and CD8/CD3 was performed
in the same tissue section using a sequential staining technique and the Chro-
moplex Dual Staining Detection system (Leica Biosystems). All antibodies were
optimised for use on parafﬁn sections with appropriate positive and negative
controls.
Image analysis. Tissue array slides were scanned on a LEICA SCN400F digital
slide scanner (Leica Microsystems), and images were analysed on the SlidePath
Digital Image Hub (Leica) with Deﬁniens Tissue Studio 3.6 (Deﬁniens AG). After
manually selecting regions of interest (ROI) in each section, analysis algorithms
were as follows: the software determined the area of each ROI (in μm²) and
identiﬁed and counted the number of nuclei (# blue), the number of HLA-E+ cells
(# brown), the number of CD8+ cells (# red) and the number of CD8+ cells
bordering HLA-E+ cells (# red bordering brown) per ROI. Counts were expressed
as cells/μm². Using this information, we deﬁned a function for HLA-E intensity ((#
brown/# blue)*100), CD8 inﬁltration ((# red/# blue)*100) and co-localisation of
CD8 and HLA-E ((# red bordering brown/# red)*100). HLA-E intensity and CD8
inﬁltration were deﬁned according to the frequency of HLA-E+ and CD8+ cells
and scored as: negative (score 0: between 0 and 1%), mild (score 1: 1–5%), mod-
erate (score 2: 5–10%) and intense (score 3: >10%). The complete data analysis is
available in Supplementary Table 3.
The p16-3MR mouse model. Experiments with p16-3MR mice were performed
under protocols approved by the Buck Institute's Animal Care and Use Committee.
Mice were given bleomycin (1.9 U/Kg, daily) or PBS via intratracheal instillation
for 14 days. Ganciclovir (25 mg/kg; daily) or vehicle were administered via intra-
peritoneal injection for 7 days starting 1-week after bleomycin treatment. Animals
were euthanized and tissues collected for analysis.
RNA isolation and real-time quantitative PCR. The total RNA from mouse lung
was isolated using Directzol RNA miniprep (Zymo Research), following the
manufacture’s protocol. RNA was reverse-transcribed using TaqMan Universal
PCR Master Mix (Applied Biosystems), and cDNA was analysed by real-time
qPCR using the Roche Universal Probe Library (UPL) system. All reactions were
performed in triplicate, and mRNA levels were normalised to averages of actin and
tubulin, unless noted otherwise. The relative amount of mRNA was determined
using the comparative threshold (Ct) method by normalising target cDNA Ct
values to that of actin/tubulin. Fold changes were calculated relative to control
(PBS) for each group using the formula 2e − ΔΔCt.
Primer sequences and probes used:
Mouse actin: F 5′-CTAAGGCCAACCGTGAAAAG-3′, R 5′-ACCAGAGGCA
TACAGGGACA-3′, UPL Probe #64;
Mouse tubulin: F 5′-CTGGAACCCACGGTCATC-3′, R 5′-GTGGCCACGAG
CATAGTTATT-3′, UPL Probe #88;
Mouse H2-T23: F 5´-AGCCCCTCACCCTGAGAT-3′, R 5′-ACCACAGCTCC
AAGGATGAT-3′, UPL Probe #94;
Mouse CDKN2A: F 5′-AATCTCCGCGAGGAAAGC-3′, R 5′-GTCTGCAGCG
GACTCCAT-3′, #91.
Statistical analysis. Statistical analysis was performed using Prism (GraphPad
Software). Depending on normality of the data, comparisons were performed using
the Student t test, the non-parametric Mann–Whitney U test (for two groups), the
Wilcoxon signed rank test (for >2 paired groups), Kruskal–Wallis (for >2 unpaired
groups) or Friedman (for >2 paired groups) one-way ANOVA tests, as appropriate.
Linear regression analysis was performed to generate lines of best ﬁt, and corre-
lations between variables were analysed using Pearson's or Spearman’s rank cor-
relation coefﬁcients (r). Two-tail P-values were calculated and considered
signiﬁcant if P < 0.05. The data are presented as means ± standard error of the
mean (SEM) unless otherwise stated. *p < 0.05, **p < 0.01, ***p < 0.001, ****p <
0.0001.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying the ﬁgures in the manuscript are provided as a Source Data
ﬁle. All other data are included in the supplemental information or available from the
authors upon reasonable requests.
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